4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GlucoTrack, Inc. (GCTK) operates in the Medical Instruments & Supplies industry and is headquartered in Rutherford, United States with about 15 employees. Its market capitalization is roughly $2 million. In the fiscal year ended 2025-12-31, GCTK reported $0M in revenue and ($19M) in net income.
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($16M) | ($14M) | ($7M) | ($4M) | — |
| Net Income | ($19M) | ($23M) | ($7M) | ($4M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($4M) | ($4M) | ($4M) | ($5M) | ($4M) | — |
| Net Income | ($4M) | ($4M) | ($4M) | ($5M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $8M | $6M | $5M | $2M | — |
| Total Liabilities | $5M | $19M | $2M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GCTK viewer.
About TickerBase · Data methodology & sources